Authors: Drusano, G

Citation: G. Drusano, Pharmacodynamic and pharmacokinetic considerations in antimicrobial selection: focus on telithromycin, CL MICRO IN, 7, 2001, pp. 24-29

Authors: Hafner, R Bethel, J Standiford, HC Follansbee, S Cohn, DL Polk, RE Mole, L Raasch, R Kumar, P Mushatt, D Drusano, G

Citation: R. Hafner et al., Tolerance and pharmacokinetic interactions of rifabutin and azithromycin, ANTIM AG CH, 45(5), 2001, pp. 1572-1577

Authors: Hanley, EM Veeder, A Smith, T Drusano, G Currie, E Venezia, RA

Citation: Em. Hanley et al., Evaluation of an antiseptic triple-lumen catheter in an intensive care unit, CRIT CARE M, 28(2), 2000, pp. 366-370

Authors: Margolis, D Heredia, A Gaywee, J Oldach, D Drusano, G Redfield, R

Citation: D. Margolis et al., Abacavir and mycophenolic acid, an inhibitor of inosine monophosphate dehydrogenase, have profound and synergistic anti-HIV activity, J ACQ IMM D, 21(5), 1999, pp. 362-370

Authors: Skowron, G Stein, D Drusano, G Melbourne, K Bilello, J Mikolich, D Rana, K Agosti, JM Mongillo, A Whitmore, J Gilbert, MJ

Citation: G. Skowron et al., The safety and efficacy of granulocyte-macrophage colony-stimulating factor (sargramostim) added to indinavir- or ritonavir-based antiretroviral Therapy: A randomized double-blind, placebo-controlled trial, J INFEC DIS, 180(4), 1999, pp. 1064-1071

Authors: Hafner, R Inderlied, CB Peterson, DM Wright, DJ Standiford, HC Drusano, G Muth, K

Citation: R. Hafner et al., Correlation of quantitative bone marrow and blood cultures in AIDS patients with disseminated Mycobacterium avium complex infection, J INFEC DIS, 180(2), 1999, pp. 438-447